Second-quarter revenues for the IBO Lab Equipment/Consumables Sales Index expanded 7.5%, 4.5% excluding currency, to $4,056.00 million. Operating profits for the Index climbed 6.3% to $721.23 million, but adjusted operating margin declined 80 basis points to 17.1% of sales. Biohit’s second-quarter sales grew 2.4% to €10.2 million ($14.8 million = €0.69 = $1) due to […]
The Woodlands, TX 10/13/11; San Jose, CA 10/13/11—Rigaku Americas has acquired BaySpec’s handheld Raman technology and products lines for an undisclosed amount. Rigaku will form a new division, Rigaku Raman Technologies, for R&D, engineering, production, marketing and distribution of the products. The first products will be the FirstGuard and Xantus series, which cover the sample […]
Männedorf, Switzerland 10/7/11—Tecan has announced the initiation of a succession process for its CEO. Tecan’s Board in coming months will elect a new CEO, replacing current CEO Thomas Bachmann, whose employment ends October 31, 2012. The company stated that the process follows its strategic realignment of the last two years, which has resulted in a […]
Shanghai, China 10/14/11—R&D services firm WuXi PharmaTech has acquired Abgent, a provider of biological research reagent products and services, for an undisclosed amount. The world’s largest manufacturer of antibody reagents for research use, according to WuXi PharmaTech, Abgent offers a catalog of 20,000 antibody products. Abgent manufactures antibodies for distribution by reagent suppliers and also […]
San Diego, CA 10/6/11—Illumina has announced that it expects third-quarter revenues of $235 million. This figure would be a 1% decrease year over year and an 18% decline from the second quarter. The company attributed the forecast to: uncertainty about US and European research-funding levels that resulted in purchasing delays for both instruments and consumables; […]
Hercules, CA 10/5/11—Bio-Rad Laboratories has acquired QuantaLife for $162 million in cash and potential future milestone payments. QuantaLife is a developer of digital PCR technology (see IBO 12/15/10), which can be used for the detection of rare mutations. The company’s Droplet Digital system (ddPCR) is used for the validation of next-generation sequencing results. “We are […]
Two recent announcements by Thermo Fisher Scientific illustrate the company’s commitment to its diagnostics business. Diagnostics is not a new market for the company but, as the news made clear, it is one in which the company has a solid position and one for which it is investing in research. Revenue for Thermo Fisher Scientific’s […]
Instrument and laboratory product company executives hold divergent opinions on the industry outlook for the next six months and related issues, according to the latest IBO Business Climate Survey. The survey is conducted twice yearly. This season’s survey of IBO subscribers was conducted anonymously via a webpage questionnaire during late September and early October. Twenty-five […]
Stockholm, Sweden 9/2/11—Perten Instruments, a provider of quality control systems for food, has acquired TexVol Instruments. TexVol Instruments supplies volume-measuring instruments and texture-analysis systems. “The complimentary nature of the instrument ranges from Perten Instruments and TexVol Instruments allows us to deliver a wider range of analytical solutions to our customers from a single source,” said […]
Aubagne, France, Goettingen, Germany and Chalfont St. Giles, UK 9/12/11—Sartorius Stedim Biotech and GE Healthcare Life Sciences have signed a patent cross-licensing agreement for biotechnology manufacturing technologies. Sartorius has granted GE a sublicense to certain patents exclusively licensed from Fluorometrix that involve bioreactors with at least two optical sensors. GE has granted Sartorius a sublicense […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
